Abstract:OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes.DESIGN: Retrospective study.MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test.RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group.CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes. OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes. DESIGN: Retrospective study. MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test. RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group. CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes.

Single Embryo Transfer by Day 3 Time-Lapse Selection Versus Day 5 Conventional Morphological Selection: a Randomized, Open-Label, Non-Inferiority Trial

Frozen Versus Fresh Single Blastocyst Transfer in Ovulatory Women: a Multicentre, Randomised Controlled Trial.

Blastocyst Culture of Human Suboptimal Embryos Does Not Improve Clinical Outcomes

A Comparison of Implantation, Miscarriage and Pregnancy Rates of Single and Double Day 3 Embryo Transfer Between Fresh and Frozen Thawed Transfer Cycles: a Retrospective Study.

Embryo Selection for Single Embryo Transfer on Day 3 Based on Combination of Cleavage Patterns and Timing Parameters in in Vitro Fertilization Patients.

The TLI system can help day-3 single cleavage embryo transfer to obtain comparative clinical outcomes to day-4 or day-5

Selection of Single Blastocysts for Transfer Via Time-Lapse Monitoring Alone and with Next-Generation Sequencing to Reduce Multiple Pregnancies: A Randomized Pilot Study.

Can Time-Lapse Incubation and Monitoring Be Beneficial to Assisted Reproduction Technology Outcomes? A Randomized Controlled Trial Using Day 3 Double Embryo Transfer

Clinical Outcomes for Day 3 Double Cleavage-Stage Embryo Transfers Versus Day 5 or 6 Single Blastocyst Transfer in Frozen–thawed Cycles: a Retrospective Comparative Analysis

A PROSPECTIVE MULTI-CENTER, RANDOMIZED STUDY TO COMPARE THE IMPLANTATION RATE (IR) OF EMBRYOS CULTURED AND ASSESSED USING TIME-LAPSE TECHNOLOGY (TLT) VS A CONVENTIONAL INCUBATOR (CI) SYSTEM

Should Blastocyst Transfer Be Performed in Patients with 1–3 Embryos Available on Day 3?

Effect of single blastocyst-stage versus single cleavage-stage embryo transfer on cumulative live births in women with good prognosis undergoing in vitro fertilization: Multicenter Randomized Controlled Trial

Comparison of embryo implantation potential between time-lapse incubators and standard incubators: A randomized controlled study

Embryo Incubation by Time-Lapse Systems Versus Conventional Incubators in Chinese Women with Diminished Ovarian Reserve Undergoing IVF/ICSI: a Study Protocol for a Randomised Controlled Trial

Clinical Outcomes of Different Embryo Transfer Strategies in IVF Treatment Cycles

One Fresh Cleavage-Stage Single Embryo Transfer (SET) Plus One Frozen-Thawed Blastocyst-Stage SET or One Fresh Cleavage-Stage Double Embryo Transfer? A Retrospective Matched Cohort Study.

Optimizing single blastocyst selection: the role of day 3 embryo morphology in vitrified-warmed blastocyst transfer cycles

Selection of Competent Blastocysts for Transfer by Combining Time-Lapse Monitoring and Array CGH Testing for Patients Undergoing Preimplantation Genetic Screening: a Prospective Study with Sibling Oocytes

Day-2 and day-3 sequential transfer improves pregnancy rate in patients with repeated IVF-embryo transfer failure: a retrospective case-control study.

Does Day 3 Embryo Status Matter to Reproductive Outcomes of Single Blastocyst Transfer Cycles? A Cohort Study

Day 3 ET, Single Blastocyst Transfer (SBT) or Frozen-Thawed Embryo Transfer (FET): Which is Preferable for High Responder Patients in IVF/ICSI Cycles?